By Frank Prenesti
Date: Friday 04 Apr 2025
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast cancer, the companies said on Friday.
By Josh White
Date: Thursday 03 Apr 2025
(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight.
By Josh White
Date: Thursday 03 Apr 2025
(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations originally set to run until 31 May.
Price | 21,726.23 |
Closing Price Change | 350.12 |
% Change | 1.64 % |
03-Apr-25 Close | 21,726.23 |
You are here: research